Skip to main content
. 2015 Jun 17;11(10):2425–2433. doi: 10.1080/21645515.2015.1055429

Table 1.

Baseline characteristics in safety analysis set

  Treatment vaccine Control vaccine
Participants, No. 830 830
Age(yrs), mean ± SD 40.17 ± 25.07 39.98 ± 24.92
Male sex, No. (%) 348(41.93) 304(36.63)
Ethnic group, No. (%)    
Han 350(42.17) 378(45.54)
Zhuang 413(49.76) 391(47.11)
Yao 13(1.57) 14(1.69)
Miao 13(1.61) 8(0.96)
Other 41(4.94) 39(4.70)